Research Alert: Henry Schein: U.s. Dental Sales Growth Supports Q1 Eps Beat
CFRA, an independent research provider, has providedwith the following research alert. Analysts at CFRA have summarized their opinion as follows:Henry Schein reported Q1 adjusted EPS of $1.32, up 14.8% Y/Y and $0.10 above consensus, while total net sales increased 6.3% Y/Y to $3.368B. Adjusted operating margin expanded 28 bps to 7.53%, supported by improvement in Global Distribution and Technology segments. We view the dental distribution strength as encouraging, with Global Dental sales rising 9.0% Y/Y to $1.766B and equipment sales up 8.6% despite the challenging higher interest rate environment pressuring equipment purchases. We believe the dental equipment growth of 8.6% Y/Y represents a positive indicator given financing constraints on buyers, while the Global Technology segment's 7.0% Y/Y growth reflects increased adoption of practice management solutions. Management reaffirmed 2026 guidance for sales, margins, and EPS. HSIC maintained its aggressive capital return strategy, repurchasing $125M of shares during Q1 with $655M remaining under authorization.